- 商品介绍
- 规格参数
- 包装参数
Biochem/physiol Actions
Chaperone-mediated autophagy (CMA) activator that rescues LAMP2A lysosomal localization in cystinotic cells and reduces toxic α-syn accumulation in PD astrocytes.
QX77 is a chaperone-mediated autophagy (CMA) activator derived from the atypical retinoid AR7 that activates CMA by antagonizing retinoic acid receptor-α (RARα) signaling. QX77 rescues defective trafficking & lysosomal localization of the CMA receptor LAMP2A in cystinotic Ctns-/- MEFs and CTNS-KO human proximal tubule cells (PTCs) by restoring Rab11 expression and Rab11-positive vesicles trafficking to the level seen in wild-type cells (20 μM, 48 hrs). CMA activation by QX77 treatment (20 μM, 5 days) also significantly reduces toxic α-synuclein (α-syn) accumulation in PD patients iPSCs-derived astrocytes with LRRK2 G2019S mutation.
| assay | ≥98% (HPLC) |
| form | powder |
| color | white to beige |
| solubility | DMSO: 2 mg/mL, clear |
| storage temp. | 2-8°C |
| SMILES string | Clc1cc2c(cc1)NC(=CO2)c3ccc(cc3)NC(=O)C |
| InChI | 1S/C16H13ClN2O2/c1-10(20)18-13-5-2-11(3-6-13)15-9-21-16-8-12(17)4-7-14(16)19-15/h2-9,19H,1H3,(H,18,20) |
| InChI key | FVNBPTNXXWCRJJ-UHFFFAOYSA-N |
| 长度(mm) | |
| 宽度(mm) | |
| 高度(mm) | |
| 重量(kg) |
-
询价
-
¥ 2814.26
-
询价
-
询价
-
询价
-
询价
-
询价
-
询价
-
询价
-
¥ 4390.38
-
¥ 1476.00
-
¥ 1749.15
-
¥ 5014.59
-
¥ 2277.64
-
¥ 165230.53
-
¥ 26846.31
-
¥ 30616.15
-
¥ 25551.73
-
¥ 52185.37
-
询价
微信小程序
7X24小时在线咨询